A Novel Therapy for Diabetic Nephropathy
ثبت نشده
چکیده
Citation: Woo KT, Chan CM, Choong HL, (2017) A Novel Therapy for Diabetic Nephropathy. J Nephrol urol. Vol. 1 No. 1: 2 The ISN (International Society of Nephrology) Global Outreach Programme confirmed that for the less developed countries, compared to the more developed ones, Chronic Glomerulonephritis (Chronic GN) and not Diabetic Nephropathy (DiabNx) is still the leading cause of end stage renal disease (ESRD) [1]. The more developed Asian countries like China, India, Malaysia and Singapore are now faced with the burden of diseases associated with lifestyle changes such as diabetes and obesity.
منابع مشابه
Assessment of Oral Glycine and Lysine Therapy on Receptor for Advanced Glycation End Products and Transforming Growth Factor Beta Expression in the Kidney of Streptozotocin-Induced Diabetic Rats in Comparison with Normal Rats
Background & Aims: Today, diabetic nephropathy is considered to be one of the most common causes of end stage renal disease. Uncontrolled hyperglycemia, and consequently, production of advanced glycation end products activate pathways which play key roles in diabetic nephropathy. Among these pathways, high expression of receptor for advanced glycation end products (RAGE) and transforming growth...
متن کاملRisk Factors for Diabetic Nephropathy in Diabetic Patients
Aims: Diabetic nephropathy is one of the consequences of type 1 and type 2 diabetes and one of the main causes of End-Stage Renal Disease (ESRD) as well as an important risk factor for cardiovascular morbidity and death. The aim of this study was to identify the risk factors for diabetic nephropathy in diabetic patients. Instruments & Methods: In this cross-sectional descriptive study, 121 pat...
متن کاملRecombinant fibromodulin has therapeutic effects on diabetic nephropathy by down-regulating transforming growth factor-β1 in streptozotocin-induced diabetic rat model
Objective(s):Diabetic nephropathy is an important long-term complication of diabetes mellitus which appears to be partially mediated by an increase in secretion of transforming growth factor-β (TGF-β). Fibromodulin, the small leucine-rich proteoglycan, has been proposed to be the potent TGFβ1 modulator. In this study, the therapeutic effects of recombinant adenoviral vectors expressing fibromod...
متن کاملAntiangiogenic Therapy for Diabetic Nephropathy
Angiogenesis has been shown to be a potential therapeutic target for early stages of diabetic nephropathy in a number of animal experiments. Vascular endothelial growth factor (VEGF) is the main mediator for abnormal angiogenesis in diabetic glomeruli. Although beneficial effects of anti-VEGF antibodies have previously been demonstrated in diabetic animal experiments, recent basic and clinical ...
متن کاملEffects of additive therapy with spironolactone on albuminuria in diabetes mellitus: A pilot randomized clinical trial
Background: Early diagnosis of albuminuria and the prevention of its progression to macroalbuminuria and diabetic nephropathy are crucial. Angiotensin converting enzyme inhibitors (ACEIs) and antagonists of angiotensin II receptors type I (ARBs) are currently used as first-line treatment for albuminuria in these patients. The present study was conducted to assess the efficacy of addition of spi...
متن کامل